Streetbeat News

Price Targets

TTWO

Stifel analyst Drew Crum has maintained a Buy rating on Take-Two Interactive (NASDAQ:TTWO) and increased the price target from $175 to $188 as reported on January 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 3:03 pm

VZ

Tigress Financial analyst Ivan Feinseth has reaffirmed a Buy rating on Verizon Communications (NYSE:VZ) and increased the price target from $45 to $50.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 3:01 pm

IBM

BMO Capital analyst Keith Bachman has maintained a 'Market Perform' rating on IBM and increased the price target from $155 to $210.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 3:01 pm

NOW

Stifel analyst Brad Reback has maintained a Buy rating on ServiceNow (NYSE:NOW) and increased the price target from $740 to $820. The report was released on January 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 3:01 pm

DD

Seven analysts have recently updated their ratings on DuPont de Nemours (NYSE:DD), with sentiments ranging from somewhat bullish to somewhat bearish. The average 12-month price target is now $75.14, down from $81.86, with a high estimate of $85.00 and a low of $69.00. Analysts have adjusted their price targets and ratings in response to market conditions and company performance. DuPont's financials show a revenue decline of -7.81% over 3 months, a net margin of 10.43%, an ROE of 1.27%, an ROA of 0.8%, and a debt-to-equity ratio of 0.33.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 3:01 pm

APH

Amphenol (NYSE:APH) has received mixed analyst ratings over the past three months, with the latest evaluations showing 3 bullish and 1 indifferent stance. The 12-month price target average for APH has risen to $110.00, up 13.02% from the previous $97.33. Analysts from Stifel, Goldman Sachs, Citigroup, and Truist Securities have adjusted their ratings and price targets, reflecting a positive outlook on the company's performance. Amphenol, a global supplier of connectors and interconnect systems, faces revenue challenges with a -2.91% decline over 3 months but maintains strong financial indicators such as a high net margin of 16.06% and ROE of 6.69%.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 3:01 pm

FTRE

Fortrea Holdings (NASDAQ:FTRE) has been analyzed by 5 analysts over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $38.6, up 16.09% from the previous $33.25. Analysts from Barclays, Jefferies, Citigroup, and Evercore ISI Group have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Fortrea Holdings, a late-stage CRO spun off from LabCorp, has shown revenue growth but faces challenges in market capitalization, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 3:00 pm

MDLZ

Stifel analyst Matthew Smith has reaffirmed a Buy rating on Mondelez International (NASDAQ:MDLZ) and increased the price target from $78 to $81, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:59 pm

WAT

Barclays analyst Luke Sergott has maintained an Underweight rating on Waters Corporation (NYSE:WAT) but increased the price target from $230 to $275.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:59 pm

TWST

Barclays analyst Luke Sergott has maintained an Overweight rating on Twist Bioscience (NASDAQ:TWST) and increased the price target from $30 to $45.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:58 pm